ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China · Delayed Price · Currency is CNY 11.36
-0.05 (-0.44%)
Sep 14, 2026, 3:04 PM CST
ChenGuang Biotech Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,802 | 1,459 | 1,802 | 1,422 | 1,147 | 732.59 |
Short-Term Investments | 564.1 | 9.81 | 14.01 | 17.02 | 13.75 | 5.07 |
Trading Asset Securities | 72.29 | 54.66 | 8.13 | 79.85 | 17.58 | 0.56 |
Cash & Short-Term Investments | 3,438 | 1,523 | 1,825 | 1,519 | 1,178 | 738.22 |
Cash Growth | -5.60% | -16.51% | 20.09% | 28.98% | 59.57% | 136.70% |
Accounts Receivable | 462.69 | 500.68 | 458.39 | 474.39 | 311.4 | 398.77 |
Other Receivables | 90.46 | 94.78 | 9.54 | 17.17 | 77.56 | 12.63 |
Receivables | 553.15 | 595.46 | 467.93 | 491.56 | 388.96 | 411.4 |
Inventory | 3,237 | 4,229 | 3,862 | 3,198 | 2,033 | 2,229 |
Prepaid Expenses | - | - | - | - | 1.48 | 0.01 |
Other Current Assets | 312.1 | 1,084 | 654.03 | 1,157 | 1,325 | 598.8 |
Total Current Assets | 7,541 | 7,431 | 6,809 | 6,367 | 4,927 | 3,977 |
Property, Plant & Equipment | 1,520 | 1,526 | 1,663 | 1,696 | 1,538 | 1,484 |
Long-Term Investments | 135.02 | 114.6 | 112.71 | 101.47 | 92.25 | 173.01 |
Goodwill | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
Other Intangible Assets | 322.92 | 323.55 | 337.01 | 304.19 | 308.9 | 265.71 |
Long-Term Deferred Tax Assets | 50.43 | 55.19 | 56.56 | 44.39 | 35.79 | 31.54 |
Long-Term Deferred Charges | 2.29 | 2.33 | 8.88 | 12.63 | 6.75 | 3.93 |
Other Long-Term Assets | 44.64 | 50.62 | 35.21 | 13.89 | 14.32 | 19.83 |
Total Assets | 9,616 | 9,504 | 9,023 | 8,540 | 6,924 | 5,955 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 96.04 | 73.27 | 153.85 | 79.53 | 55.96 | 36.09 |
Accrued Expenses | 111.56 | 131.57 | 117.45 | 122.58 | 146.93 | 105.49 |
Short-Term Debt | 5,073 | 4,111 | 2,304 | 2,599 | 2,043 | 1,839 |
Current Portion of Long-Term Debt | 197.15 | 958.59 | 1,537 | 750.56 | 0.62 | 300.52 |
Current Portion of Leases | 0.37 | 1.05 | 0.23 | 0.22 | 0.21 | 0.06 |
Current Income Taxes Payable | 7.17 | 21.07 | 18.82 | 41.16 | 41.82 | 18.22 |
Current Unearned Revenue | 263.43 | 335.48 | 335.29 | 236.04 | 365.61 | 307.91 |
Other Current Liabilities | 136.59 | 149.96 | 129.95 | 123.01 | 102.82 | 75.03 |
Total Current Liabilities | 5,885 | 5,782 | 4,596 | 3,952 | 2,757 | 2,682 |
Long-Term Debt | 45 | 50 | 1,068 | 865 | 770 | 303.1 |
Long-Term Leases | 0.95 | 0.93 | 3.56 | 3.79 | 4 | 2.67 |
Long-Term Unearned Revenue | 172.9 | 175.19 | 150.44 | 117.72 | 93.69 | 83.6 |
Long-Term Deferred Tax Liabilities | 20.46 | 21.52 | 14.7 | 16.57 | 16.64 | 14.56 |
Other Long-Term Liabilities | 36.22 | 35.37 | 35.12 | 52.23 | 68.08 | 85.79 |
Total Liabilities | 6,161 | 6,065 | 5,868 | 5,007 | 3,710 | 3,172 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 483.1 | 483.1 | 483.1 | 532.77 | 532.77 | 532.77 |
Additional Paid-In Capital | 579.5 | 579.5 | 581.98 | 1,022 | 1,022 | 1,025 |
Retained Earnings | 2,427 | 2,394 | 2,085 | 2,056 | 1,662 | 1,294 |
Treasury Stock | - | - | - | -95.84 | - | - |
Comprehensive Income & Other | -90.12 | -67.36 | -40.87 | -44.2 | -51.43 | -67.2 |
Total Common Equity | 3,400 | 3,389 | 3,109 | 3,470 | 3,165 | 2,785 |
Minority Interest | 55.63 | 49.87 | 45.2 | 61.79 | 49.26 | -2.1 |
Shareholders' Equity | 3,456 | 3,439 | 3,155 | 3,532 | 3,214 | 2,783 |
Total Liabilities & Equity | 9,616 | 9,504 | 9,023 | 8,540 | 6,924 | 5,955 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,316 | 5,122 | 4,912 | 4,218 | 2,818 | 2,445 |
Net Cash (Debt) | -1,878 | -3,599 | -3,088 | -2,699 | -1,640 | -1,707 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.91 | -7.45 | -5.97 | -5.07 | -3.08 | -3.23 |
Filing Date Shares Outstanding | 483.1 | 483.1 | 483.1 | 532.77 | 532.77 | 532.77 |
Total Common Shares Outstanding | 483.1 | 483.1 | 483.1 | 532.77 | 532.77 | 532.77 |
Working Capital | 1,656 | 1,649 | 2,213 | 2,415 | 2,170 | 1,295 |
Book Value Per Share | 7.04 | 7.02 | 6.44 | 6.51 | 5.94 | 5.23 |
Tangible Book Value | 3,076 | 3,065 | 2,772 | 3,166 | 2,855 | 2,519 |
Tangible Book Value Per Share | 6.37 | 6.34 | 5.74 | 5.94 | 5.36 | 4.73 |
Buildings | 992.43 | 983.26 | 968.65 | 865.58 | - | 709.91 |
Machinery | 1,612 | 1,582 | 1,549 | 1,359 | - | 1,139 |
Construction In Progress | 94.48 | 73.46 | 112.43 | 295.48 | - | 219.84 |